Cargando…
Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?
Background and study aims It is uncertain if the difference in weight loss outcomes between different endoscopic bariatric therapies (EBTs) is technique-related or multidisciplinary team (MDT) follow-up-related. We hypothesized that at 1 year, the weight loss is determined more by adherence to MDT...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887647/ https://www.ncbi.nlm.nih.gov/pubmed/31803819 http://dx.doi.org/10.1055/a-1007-1769 |
_version_ | 1783475064016994304 |
---|---|
author | Lopez-Nava, Gontrand Asokkumar, Ravishankar Rull, Angel Corbelle, Fernandez Beltran, Lucia Bautista, Inmaculada |
author_facet | Lopez-Nava, Gontrand Asokkumar, Ravishankar Rull, Angel Corbelle, Fernandez Beltran, Lucia Bautista, Inmaculada |
author_sort | Lopez-Nava, Gontrand |
collection | PubMed |
description | Background and study aims It is uncertain if the difference in weight loss outcomes between different endoscopic bariatric therapies (EBTs) is technique-related or multidisciplinary team (MDT) follow-up-related. We hypothesized that at 1 year, the weight loss is determined more by adherence to MDT follow-up than by procedure type. We aimed to compare 1 year weight loss outcomes of four different EBTs at a single center with a standardized MDT follow-up. Patients and methods We prospectively collected and retrospectively analyzed outcomes in 962 patients (female-691, 71.2 %; mean age, 44.8 ± 10.6 years, mean BMI, 37.8 ± 5.9 Kg/m (2) ) treated with Intragastric balloons (IGBs) or endoscopic gastroplasty (EG) at HM Sanchinarro University Hospital between March 2012 to January 2017. The procedures were performed by the same endoscopist and followed up by the same MDT. We compared the percentage total body weight loss (%TWBL) at 1 year. We performed linear and logistic regression to identify predictive factors for weight loss and follow-up adherence at 1 year. Results Four hundred and eighty-one IGBs (Orbera-80.9 %; ReShape Duo-19.1 %), and 481 EG (Apollo ESG-51.3 %; Primary obesity surgery endoluminal-POSE-48.6 %) were performed. Only 480 patients (IGB- 45 %; EG- 55 %) completed 1 year follow-up. Among them, Apollo ESG achieved significantly higher TBWL (19.5 ± 13 %, P = 0.035), %TBWL (17.4 ± 10.2 %, P = 0.025), and ≥ 20 % TBWL (36.7 %, P = 0.032). However, in linear regression after adjusting for variables, only higher initial BMI (B = 0.31, P < 0.001) and higher percentage follow-up attendance (B = 0.24, P < 0.001) significantly predicted %TBWL at 1 year in the completion group but not the procedure type (B = 0.02, P = 0.72). In logistic regression, we observed female sex ( P = 0.01), high initial BMI ( P < 0.001), endoscopic gastroplasty ( P = 0.04), and high 1-month %TBWL ( P < 0.001) significantly predicted follow-up completion at 1 year. Conclusions Weight loss at 1 year is dependent on MDT follow-up rather than procedure type. Endoscopic gastroplasty promoted follow-up adherence more than IGBs. |
format | Online Article Text |
id | pubmed-6887647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | © Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-68876472019-12-04 Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? Lopez-Nava, Gontrand Asokkumar, Ravishankar Rull, Angel Corbelle, Fernandez Beltran, Lucia Bautista, Inmaculada Endosc Int Open Background and study aims It is uncertain if the difference in weight loss outcomes between different endoscopic bariatric therapies (EBTs) is technique-related or multidisciplinary team (MDT) follow-up-related. We hypothesized that at 1 year, the weight loss is determined more by adherence to MDT follow-up than by procedure type. We aimed to compare 1 year weight loss outcomes of four different EBTs at a single center with a standardized MDT follow-up. Patients and methods We prospectively collected and retrospectively analyzed outcomes in 962 patients (female-691, 71.2 %; mean age, 44.8 ± 10.6 years, mean BMI, 37.8 ± 5.9 Kg/m (2) ) treated with Intragastric balloons (IGBs) or endoscopic gastroplasty (EG) at HM Sanchinarro University Hospital between March 2012 to January 2017. The procedures were performed by the same endoscopist and followed up by the same MDT. We compared the percentage total body weight loss (%TWBL) at 1 year. We performed linear and logistic regression to identify predictive factors for weight loss and follow-up adherence at 1 year. Results Four hundred and eighty-one IGBs (Orbera-80.9 %; ReShape Duo-19.1 %), and 481 EG (Apollo ESG-51.3 %; Primary obesity surgery endoluminal-POSE-48.6 %) were performed. Only 480 patients (IGB- 45 %; EG- 55 %) completed 1 year follow-up. Among them, Apollo ESG achieved significantly higher TBWL (19.5 ± 13 %, P = 0.035), %TBWL (17.4 ± 10.2 %, P = 0.025), and ≥ 20 % TBWL (36.7 %, P = 0.032). However, in linear regression after adjusting for variables, only higher initial BMI (B = 0.31, P < 0.001) and higher percentage follow-up attendance (B = 0.24, P < 0.001) significantly predicted %TBWL at 1 year in the completion group but not the procedure type (B = 0.02, P = 0.72). In logistic regression, we observed female sex ( P = 0.01), high initial BMI ( P < 0.001), endoscopic gastroplasty ( P = 0.04), and high 1-month %TBWL ( P < 0.001) significantly predicted follow-up completion at 1 year. Conclusions Weight loss at 1 year is dependent on MDT follow-up rather than procedure type. Endoscopic gastroplasty promoted follow-up adherence more than IGBs. © Georg Thieme Verlag KG 2019-12 2019-12-02 /pmc/articles/PMC6887647/ /pubmed/31803819 http://dx.doi.org/10.1055/a-1007-1769 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Lopez-Nava, Gontrand Asokkumar, Ravishankar Rull, Angel Corbelle, Fernandez Beltran, Lucia Bautista, Inmaculada Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? |
title | Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? |
title_full | Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? |
title_fullStr | Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? |
title_full_unstemmed | Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? |
title_short | Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? |
title_sort | bariatric endoscopy procedure type or follow-up: what predicted success at 1 year in 962 obese patients? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887647/ https://www.ncbi.nlm.nih.gov/pubmed/31803819 http://dx.doi.org/10.1055/a-1007-1769 |
work_keys_str_mv | AT lopeznavagontrand bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients AT asokkumarravishankar bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients AT rullangel bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients AT corbellefernandez bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients AT beltranlucia bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients AT bautistainmaculada bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients |